Repaglinide and related hypoglycemic benzoic acid derivatives

Journal of Medicinal Chemistry

Volumn 41, Issue 26, 1998, Pages 5219-5246

  Grell, Wolfgang ^a   Hurnaus, Rudolf ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID DERIVATIVE; GLIBENCLAMIDE; GLIMEPIRIDE; INSULIN; MEGLITINIDE; REPAGLINIDE;

ARTICLE; DRUG CONFORMATION; ENANTIOMER; FOOD AND DRUG ADMINISTRATION; HYPOGLYCEMIA; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BENZOIC ACIDS; BLOOD GLUCOSE; CARBAMATES; CRYSTALLOGRAPHY, X-RAY; FEMALE; GLYBURIDE; HYPOGLYCEMIC AGENTS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PIPERIDINES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; RECEPTORS, DRUG; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONYLUREA COMPOUNDS;

EID: 0032542255     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9810349     Document Type: Article

References (69)

1. Scheen, A. J.; Lefèbre, P. J. Pathophysiology of Type 2 Diabetes Mellitus. In Oral Antidiabetics; Kuhlmann, J., Puls, W., Eds.; Springer-Verlag: Berlin, 1996; pp 7-42.
2. See overview: Oral Antidiabetics; Kuhlmann, J., Puls, W., Eds.; Springer-Verlag: Berlin, 1996.
3. Eliasson, L.; Renström, E.; Ämmälä, C.; Berggren, P.-O.; Bertorello, A. M.; Bokvist, K.; Chibalin, A.; Deeney, J. T.; Flatt, P. R.; Gabel, J.; Gromada, J.; Larsson, O.; Lindström, P.; Rhodes, C. J.; Rorsman, P. PKC-Dependent Stimulation of Exocytosis by Sulfonylureas in Pancreatic βCells. Science 1996,277, 813815.
4. Geisen, K.; Hübner, M.; Kitzel, V.; Hrstka, V. E.; Pfaff, W.; Bosies, E.; Regitz, G.; Kühnle, H. F.; Schmidt, F. H.; Weyer, R. Acylaminoalkyl-substituierte Benzoe- und Phenylalkan-säuren mit blutglukose-senkender Wirkung. Arzneim.-Forsch. I Drug Res. 1978, 28, 1081-1083.
5. Rufer, C.; Losert, W. Blood Glucose Lowering Sulfonamides with Asymmetric Carbon Atoms. 3. Related N-Substituted Carbamoyl-benzoic Acids. J. Med. Chem. 1979, 22, 750-752.
6. Brown, G. R.; Foubister, A. J. Receptor Binding Sites of Hypoglycemic Sulfonylureas and Related [(Acylamino)alkyljbenzoic Acids. J. Med. Chem. 1984, 27, 79-81.
7. Fussgänger, R. D.; Wojcikowski, C. Stimulation of Insulin Secretion of the Isolated Perfused Rat Pancreas by a new Hypoglycemic Agent, an Acyl-amino-alkyl Benzoic Acid Derivative. Diabetologia 1977, 13, 394-395 (Abstr. 98).
8. Blayac, J.-P.; Loubatières-Mariani, M.-M.; Ribes, G. Effets in vitro d'un dérivé acyl-amino-alkyl de l'acide benzoique: Le HB 699, sur la sécrétion d'insuline et de glucagon. J. Pharmacol. (Paris) 1979, 10, 229-238.
9. Henquin, J. C.; Garrino, M. G.; Nenquin, M. Stimulation of insulin release by benzoic acid derivatives related to the nonsulfonylurea moiety of glibenclamide: structural requirements and cellular mechanisms. Eur. J. Pharmacol. 1987, 141, 243251.
10. Ribes, G.; Trimble, E. R.; Blayac, J. P.; Wollheim, C. B.; Loubatières-Mariani, M. M. Diabetologia 1981, 20, 501-505,
11. + currents in pancreatic B-cells. Naunyn Schmiedebergs Arch. Pharmacol. 1988, 337, 225-230.
12. Panten, U.; Burgfeld, J.; Goerke, F.; Rennicke, M.; Schwanstecher, M.; Wallasch, A.; Zünkler, B. J.; Lenzen, S. Control of insulin secretion by Sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem. Pharmacol. 1989, 38, 1217-1229.
13. Weyer, R.; Hitzel, V.; Geisen, K; Pfaff, W. Benzoic Acids and Their Derivatives. German Pat. Appl. 2500157, 1975.
14. Staab, A. Neuere Methoden der präparativen organischen Chemie. IV. Synthesen mit heterocyclischen Amiden (Azoliden). Angew. Chem. 1962, 74, 407-423.
15. (a) Gall, R.; Bosies, E. German Pat. Appl. 3540150, 1985, Example 14.
16. (b) Blicke, F. F.; Lilienfeld, W. M. Basic-alkyl Esters of p-(AminoalkyI)-benzoic Acids. I. J. Am. Chem. Soc. 1943, 65, 2281-2284.
17. Hitzel, V.; Weyer, R.; Geisen, K.; Ritzel, H. Salicylsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung. European Pat. Appl. 0090369, 1983, Examples l and 2.
18. (a) Appel, R.; Bäumer, G.; Strüver, W. Über die Peptidsynthese mit Triphenylphosphin/Tetrachlorkohlenstoff als Kondensationsreagenz. 27. Chem. Ber. 1975, 108, 2680-2692.
19. (b) Appel, R.; Bäumer, G.; Strüver, W. Notiz über die Peptidsynthese mit Triphenylphosphin/Tetrachlorkohlenstoff als Kondensationsreagenz. 30. Chem. Ber. 1976, 109, 801-804.
20. Wendlberger, G. Aktivierung mit Carbodiimiden. In Synthese von Peptiden; Wünsch, E., Ed.; Georg Thieme Verlag: Stuttgart, 1974; pp 103-117.
21. Maillard, J.; Langlois, M.; Delaunay, P.; Van Tri, V.; Morin, R.; Lefebvre, M.-J.; Manuel, C.; Verro, A.-M. Anti-inflammatoires dérivés de l'acide phénylacétique; dérivés substitués par un hétérocycle sur le noyau phényle. Chim. Thérap. 1973, 4, 487494.
22. Analogously to: Dodsworth, D. J.; Pia-Calcagno, M.; Ehrmann, E. U.; Quesada, A. M.; Nunez S. O.; Sammes, P. G. A New Route to Dihydroisoquinolones. J. Chem. Soc., Perkin Trans I 1983, 1453-1458.
23. Analogously to Rufer, C.; Biere, H.; Ahrens, H.; Loge, O.; Schröder, E. Blood Glucose Lowering Sulfonamides with Asymmetric Carbon Atoms. 1. J. Med. Chem. 1974, 17, 708-715.
24. Analogous to (a) Demailly, G.; Solladié, G. Asymmetric Induction in the Reduction of Chiral Imines. A Stereospecific Synthesis of 20α-Amino-5α-pregnan-3β-ol (Funtuphyllamine A) Tetrahrahedron Lett. 1975, 2471-2472.
25. (b) Frahm, A. W.; Knupp, G. Asymmetric Synthesis of cis-2-Substituted Cyclohexaneamines with High Optical Purity. Tetrahedron Lett. 1981, 2633-2336.
26. Noyori, R.; Ohta, M.; Hsiao, Y.; Kitamura, M.; Ohta, T.; Takaya, H. Asymmetric Synthesis of Isoquinoline Alkaloids by Homogeneous Catalysis. J. Am. Chem. Soc. 1986, 108, 7117-7119.
27. Analogously to: Nudelman, A.; Cram, D. J. The Stereochemical Course of Ester-Amide Interchange Leading to Optically active Phosphinic and Sulfinic Amides. J. Am. Chem. Soc. 1968, 90, 3869-3870.
28. Snatzke, G. (University of Bochum, Germany). Unpublished results.
29. 4]. Tetrahedron 1981, 37, 349-361.
30. Barton, D. H. R.; Frelek, J.; Snatzke, G. Circular Dichroism of In-Situ Trinuclear Organo-transition Metal Complexes with Optically Active Ligands. J. Phys. Org. Chem. 1988, 1, 33-38.
31. Brockmann, H., Jr.; Risch, N. Modifizierte Horeau-Analyse zur Chiralitätsbestimmung von Aminen, Alkoholen und Carbonsäuren. Angew. Chem. 1974, 86, 707-708.
32. Hitzel, V.; Weyer, R.; Bosies, E. Acylamino(alkyl)benzene derivatives. German Patent Application 2600513, 1976; Example 4.
33. Aumüller, W.; Bänder, A.; Heerdt, R ; Muth, K.; Pfaff, W.; Schmidt, F. H.; Weber, H.; Weyer, W. Ein neues hochwirksames orales Antidiabeticum. Arzneim.-Forsch. /Drug Res. 1966, 16, 1640-1641.
34. Weyer, R.; Hitzel, V. Acylureidoalkylphenylsulfonylureas with Blood Glucose Lowering Efficacy. Arzneim.-Forsch. I Drug Res. 1988, 38, 1079-1080.
35. Weyer, R.; Hitzel, V.; Geisen, K; Regitz, G. Sulfonylharnstoffe, Verfahren zu ihrer Herstellung und pharmazeutische Präparate enthaltend diese Verbindungen. European Patent 0031058,1980 (DE 1979); Example 19.
36. Mark, M.; Grell, W. Hypoglycaemic Effects of the Novel Antidiabetic Agent Repaglinide in Rats and Dogs. Br. J. Pharmacol. 1997, 121, 1597-1604.
37. Graul, A.; Castaner, J. Repaglinide. Drugs Fut. 1996,21, 694699.
38. Presented in part at the IXth International Symposium on Medicinal Chemistry, Sept 14-18,1986, Berlin, West-Germany. Short Communication (Abstract SC 74). Grell, W.; Griss, G. (deceased); Hurnaus, R.; Sauter, R.; Rupprecht, E. StructureActivity Relationships of Novel Hypoglycémie Benzoic Acids.
39. Presented in part at the 16th International Diabetes Federation Congress, Helsinki, Finland, July 20-25, 1997. Grell, W.; Hurnaus, R.; Griss, G. (deceased); Rupprecht, E.; Mark, M.; Luger, P. Repaglinide, a Potent and Orally Active Hypoglycaemic Benzoic Acid Derivative. Diabetologia 1997,40 (Suppl. 1), A325 (No. 1278).
40. Presented in part at the XVIth Congress and General Assembly of the International Union of Crystallography, August 21-29, 1993, Beijing, China. Grell, W.; Mark, M.; Luger, P. X-ray Analysis of the New Hypoglycemic Drug Repaglinide: Common Structural Features with Glibenclamide. Acta Crystallogr. 1993, A49 (Suppl.), 126 (Abstract MS-04.01.08).
41. Presented in part at the 16th International Diabetes Federation Congress, Helsinki, Finland, July 20-25,1997. Grell, W.; Mark, M.; Luger, P.; Nar, H.; Wittneben, H.; Müller, P. Repaglinide Differs Structurally from the Sulphonylureas Glibenclamide and Glimepiride. Diabetologia 1997,40 (Suppl. 1), A321 (No. 1264).
42. Fuhlendorff, J.; Shymo, R.; Carr, R. D.; Kofod, H. Characterization of the binding sites for the novel anti-hyperglycaemic drug, repaglinide. Diabetes 1995, 44 (Suppl. 1), Abstract 848.
43. Fuhlendorff, J.; Carr, R. D.; Kofod, H.; Rorsman P. The mechanism of action of repaglinide differs to sulphonylureas in murine βcells. Pharmacol. Res. 1995, 31 (Suppl. 1), 32.
44. (b) Fuhlendorff, J.; Rorsman, P.; Kofod, H.; Brand, C. L.; Rolin, B.; MacKay, P.; Shymko, R.; Carr, R. D. Stimulation of Insulin Release by Repaglinide and Glibenclamide Involves Both Common and Distinct Processes. Diabetes 1998, 47, 345-351.
45. Byrn, S. R.; McKenzie, A. T.; Hassan, M. M. A.; Al-Badr, A. A. Conformation of glyburide in the solid state and in solution. J. Pharm. Sei. 1986, 75, 696-600.
46. Lins, L.; Brasseur, R.; Malaisse, W. J. Conformational Analysis of Non-Sulfonylurea Hypoglycemic Agents of the Meglitinide Family. Biochem. Pharmacol. 1995, 50, 1879-1884.
47. Rufer, C.; Biere, H.; Ahrens, H.; Loge, O.; Schröder, E. Blood Glucose Lowering Sulfonamides with Asymmetric Carbon Atoms. 1. J. Med. Chem. 1974, 17, 708-715.
48. (a) Bowman, R. E.; Stroud, H. H. N-Substituted Amino-acids. Part I. A New Method of Preparation of Dimethylamino-acids. J. Chem. Soc. 1950, 1343-1345.
49. (b) Kuhn, R.; Gelder, K. Ultraviolett- und fluoreszenz-spektroskopische Untersuchungen zur Ermittlung der Aminocarbonsäure- und der ZwitterionStruktur bei solvatisierten 2-Amino-benzoesäuren. Chem Der. 1968, 101, 3587-3596.
50. Garner, G. V.; Mobbs, D. B.; Suschitzky, H.; Millership, J. S. Syntheses of Heterocyclic Compounds. Part XXIV. Cyclisation Studies with ortho-Substituted Arylcarbene and Arylnitrene Precursors. J. Chem. Soc. 1971, 3693-3701.
51. Holland, G. F. (Pfizer). Procédé pour préparer des acides 5-sulfamyl benzoiques substitués en 2. Belg. Patent 772381, 1971, Examples 1 and 2. (Derwent 19603T).
52. Ruzicka, L.; Kobelt, M.; Háflger, O.; Prelog, V. 69. Vielgliedrige heterocyclische Verbindungen. 12. Mitteilung. Polymethylenimine. Helv. Chim. Ada 1949, 32, 544-552.
53. Thorp, L.; Brunskill, E. R. o- And p-Chlorobenzoylacetic Esters And Some Of Their Derivatives. J,. 4m. Chem. Soc. 1915, 37, 1258-1264.
54. Cope, A. C.; Foster, T. T.; Towle, P. H. Thermal Decomposition of Amine Oxides to Olefins and Dialkylhydroxylamines. J. Am. Chem. Soc. 1949, 71, 3929-3935.
55. Lindberg, U. H.; Jakupovic, E.; Nylén, B.; Ulff, B.; Åkerman, B. Potential Local Anaesthetics. III. Basic N-(Ring Substituted α,αDialkylbenzyDacylamines. Acta Pharm. Suecica 1970, 7, 531542.
56. Jansen, J. R.; Littmann, M. Verfahren zur Racemisierung von optisch aktiven 1-Aryl-alkylaminen. European Patent Application EP-A 0489682, 1991, Example 3.
57. Cremlyn, R. J. W.; Hornby, R. Sulphonylhydrazides and Related Compounds. Part XI. Some Substituted Aryl Ether Sulphonylhydrazides. J. Chem. Soc. C 1969, 1341-1345.
58. Havinga, E.; Veldstra, H. Researches on Sulphanilamide, paraAmino-benzoic Acid and their Derivatives. III. UV-absorption Spectra and Potentiometric Titrations. Rec. Trav. Chim. PaysBas 1947, 66, 257-272.
59. (a) Parham, W. E.; Rinehart, J. K. 1,3-Bridged Aromatic Systems. II. A New Synthesis of Metacyclophanes. J. Am. Chem. Soc. 1967, 89, 5668-5673.
60. (b) Parham, W. E.; Wright, C. D.; Bolon, D. A. The Diazotation of o-(l-Cycloalkenyl)-benzylamines. The Synthesis of Condensed Hydrocarbons. J. Am. Chem. Soc. 1961, 83, 1751-1754.
61. Pfeiffer, P.; Engelhardt, I.; Alfuss, W. Zur Veresterung aromatischer und olefinischer Nitrile. Lieb. Ann. Chem. 1928, 467, 158-190.
62. teXsan: Crystal Structure Analysis Package, Molecular Structure Corporation, 1985 & 1992.
63. SIR92: Altomare, A.; Burla, M. C.; Camalli, M.; Cascarano, M.; Giacovazzo, C.; Guagliardi, A.; Polidori, G. J. Appl. Crystallogr. 1994, 27, 435-436.
64. SYBYL Software package Version 6.25; Tripos Associates: St. Louis, MO, 1996.
65. Gaussian 94, Revision E.3; Frisch, M. J.; et al. Gaussian Inc.: Pittsburgh, PA, 1994.
66. Kellogg, G. E.; Joshi, G. S.; Abraham, D. J. Med. Chem. Res. 1992, 1, 444-453.
67. Hint: Software add-on for Insightll Version 2.011.; EduSoa Corp.: Ashland, VA, 1996.
68. InsightII Software package Version 95.0, Molecular Simulations Inc.: San Diego, CA, 1996.
69. MOPAC93: Stewart, J. J. P. Fujitsu Ltd.: Tokyo, Japan, 1993.